FindMyKOL
Clinical trialNCT04046107WithdrawnPhase 1/PHASE2Interventional

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment0Hepatitis B Virus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and immunotherapeutic activity of cemiplimab in participants with hepatitis B virus (HBV) on suppressive antiviral therapy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • 12201, Hospital Nossa Senhora Da Conceicao Crs

    Porto Alegre, Brazil

  • 12101, Instituto de Pesquisa Clinica Evandro Chagas (ipec) Crs

    Rio de Janeiro, Brazil

Canada
  • Toronto General Hospital Crs

    Toronto, Ontario, Canada

Thailand
  • Thai Red Cross Aids Research Centre (trc-Arc) Crs (site # 31802)

    Bangkok, Thailand

  • Chiang Mai University Hiv Treatment (cmu Hiv Treatment) Crs (site Id: 31784)

    Chiang Mai, Thailand

United States
  • Ucsf Hiv/aids Crs

    San Francisco, California, United States

  • the Ponce de Leon Center Crs

    Atlanta, Georgia, United States

  • Massachusetts General Hospital Crs (mgh Crs)

    Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cemiplimab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jan 2024
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
7 Sept 2023
Registered enrollment
0
Registry id
NCT04046107
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.